Transactions

Sell Side Advisor

Duff & Phelps Advised Comprehensive Clinical Development on the Sale of its Late Phase Division to Clinical Research Advantage, Inc.

Comprehensive Clinical Development's Late Phase Division has been acquired by Clinical Research Advantage, Inc.

In July 2013, Comprehensive Clinical Development (CCD) sold its Late Phase Division to Clinical Research Advantage, Inc., (CRA) a portfolio company of private equity firm, Kinderhook Industries, LLC.

About Comprehensive Clinical Development
Comprehensive Clinical Development is a clinical research company focusing on clinical pharmacology, central nervous system (CNS) and oncology trials. CCD’s Late Phase Division is an industry leader in conducting psychiatric clinical trials, specifically in the areas of Schizophrenia, Bipolar Disorder, Depression, and Alzheimer's Disease, and operates four independent sites in Atlanta (GA), Cerritos (CA), Holliswood (NY) and Washington, D.C.

About Clinical Research Advantage, Inc.
Based in Tempe, Arizona, CRA is a leading trial management organization that provides Phase II - IV clinical trials management services to the pharmaceutical and biotechnology industries. CRA matches pharmaceutical, biotechnology and contract research organizations with its partner medical practices to recruit patients and conduct clinical trials. CRA has provided research services to the pharmaceutical and medical device industries since 1990, and has successfully completed over 10,800 clinical trials.

Transaction Role
Duff & Phelps acted as the exclusive financial advisor to CCD in connection with CCD’s §363 sale process pursuant to the U.S. Bankruptcy Code and provided M&A advisory services in connection with the sale of CCD’s Late Phase Division to CRA.

Stay Ahead with Kroll

Mergers and Acquisitions (M&A) Advisory

Mergers and Acquisitions (M&A) Advisory

Kroll’s investment banking practice has extensive experience in M&A deal strategy and structuring, capital raising, transaction advisory services and financial sponsor coverage.

Valuation Services

Valuation Services

When companies require an objective and independent assessment of value, they look to Kroll.

Corporate Finance and Restructuring

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Fairness Opinions

Fairness Opinions

#1 ranked provider of fairness opinions for boards of directors and special committees.

Transaction Advisory Services

Transaction Advisory Services

Kroll’s Transaction Advisory Services platform offers corporate and financial investors with deep accounting and technical expertise, commercial knowledge, industry insight and seamless analytical services throughout the deal continuum.

Related Case Studies
Return to top